Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125738311 | 12573831 | 1 | I | 2007 | 20160712 | 20160720 | 20160720 | EXP | US-ASTRAZENECA-2016SE76336 | ASTRAZENECA | 57.00 | YR | F | Y | 81.60000 | KG | 20160720 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125738311 | 12573831 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | 10.0UG UNKNOWN | Y | U | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | |||||
| 125738311 | 12573831 | 2 | C | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | 0 | |||||||||||
| 125738311 | 12573831 | 3 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 1000 | MG | BID | ||||||||
| 125738311 | 12573831 | 4 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 112.0UG/ML UNKNOWN | 0 | 112 | |||||||||
| 125738311 | 12573831 | 5 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 125738311 | 12573831 | 6 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 81 | MG | QD | ||||||||
| 125738311 | 12573831 | 7 | C | TRIAMTERENE. | TRIAMTERENE | 1 | Oral | 37.5MG UNKNOWN | 0 | 37.5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125738311 | 12573831 | 1 | Type 2 diabetes mellitus |
| 125738311 | 12573831 | 2 | Type 2 diabetes mellitus |
| 125738311 | 12573831 | 3 | Type 2 diabetes mellitus |
| 125738311 | 12573831 | 4 | Thyroid disorder |
| 125738311 | 12573831 | 5 | Blood cholesterol abnormal |
| 125738311 | 12573831 | 6 | Cardiac disorder |
| 125738311 | 12573831 | 7 | Dizziness |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125738311 | 12573831 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125738311 | 12573831 | Body height decreased | |
| 125738311 | 12573831 | Breast cancer | |
| 125738311 | 12573831 | Dizziness | |
| 125738311 | 12573831 | Eustachian tube disorder | |
| 125738311 | 12573831 | Glycosylated haemoglobin decreased | |
| 125738311 | 12573831 | Headache | |
| 125738311 | 12573831 | Nasopharyngitis | |
| 125738311 | 12573831 | Nausea | |
| 125738311 | 12573831 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125738311 | 12573831 | 1 | 2004 | 2007 | 0 |